Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Donanemab's trials
ALADDIN
Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation
Donanemab
Ongoing
Not yet recruiting
Phase 4
Open NCT06911944 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
ALADDIN · Trial Tracker · ComplyRx
